Health Condition 1: B449- Aspergillosis, unspecified Health Condition 2: B409- Blastomycosis, unspecified Health Condition 3: B376- Candidal endocarditis Health Condition 4: B375- Candidal meningitis Health Condition 5: B377- Candidal sepsis Health Condition 6: B378- Candidiasis of other sites Health Condition 7: B379- Candidiasis, unspecified Health Condition 8: A00-B99- Certain infectious and parasitic diseases Health Condition 9: B439- Chromomycosis, unspecified Health Condition 10: B459- Cry
Conditions
Interventions
None listed
Sponsors
ASHIQUE ALI N K
Eligibility
Inclusion criteria
Inclusion criteria: Patients admitted in St John’s Medical College Hospital ICU fulfilling the criteria during the study period will be eligible for inclusion 1. Patient admitted in the ICU, already started on systemic antifungal therapy. 2. Patients above 18years of age 3. Both medical and surgical patients.
Exclusion criteria
Exclusion criteria: 1. Patients below 18 years of age. 2. Nonconsenting patients
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| ICU length of stay Hospital mortality 28-day mortality Timepoint: ICU admission days Hospital days after discharging from the ICU 28th day | — |
Primary
| Measure | Time frame |
|---|---|
| factors influencing initiation of antifungals in ICUTimepoint: ICU admission days when antifungal therapy was started | — |
Countries
India
Contacts
Public ContactASHIQUE ALI N K
St. Johns medical college Bangalore
Outcome results
None listed